Travere Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Travere Therapeutics by Credit Suisse
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $917k | 102k | 8.99 |
2023-09-30 | $551k | 62k | 8.94 |
2023-06-30 | $1.3M | 87k | 15.36 |
2023-03-31 | $1.2M | 54k | 22.49 |
2022-12-31 | $953k | 45k | 21.03 |
2022-09-30 | $1.2M | 47k | 24.67 |
2022-06-30 | $1.0M | 42k | 24.17 |
2022-03-31 | $1.2M | 45k | 25.78 |
2021-12-31 | $1.4M | 46k | 31.08 |
2021-09-30 | $972k | 40k | 24.34 |
2021-06-30 | $477k | 33k | 14.42 |
2021-03-31 | $1.0M | 36k | 28.99 |
2020-12-31 | $1.6M | 61k | 25.64 |